152 related articles for article (PubMed ID: 34034542)
21. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
[TBL] [Abstract][Full Text] [Related]
22. An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.
Xie F; Dong D; Du N; Guo L; Ni W; Yuan H; Zhang N; Jie J; Liu G; Tai G
Mol Med Rep; 2019 Oct; 20(4):2990-3002. PubMed ID: 31432147
[TBL] [Abstract][Full Text] [Related]
23. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
24. Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.
Chen H; Deng Q; Wang W; Tao H; Gao Y
J Ovarian Res; 2020 Nov; 13(1):131. PubMed ID: 33160404
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation profiling analysis identifies a DNA methylation signature for predicting prognosis and recurrence of lung adenocarcinoma.
Wang R; Zhu H; Yang M; Zhu C
Oncol Lett; 2019 Dec; 18(6):5831-5842. PubMed ID: 31788056
[TBL] [Abstract][Full Text] [Related]
26. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
[TBL] [Abstract][Full Text] [Related]
27. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
[TBL] [Abstract][Full Text] [Related]
28. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer.
Haldrup C; Mundbjerg K; Vestergaard EM; Lamy P; Wild P; Schulz WA; Arsov C; Visakorpi T; Borre M; Høyer S; Orntoft TF; Sørensen KD
J Clin Oncol; 2013 Sep; 31(26):3250-8. PubMed ID: 23918943
[TBL] [Abstract][Full Text] [Related]
30. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
32. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
33. Integrative analysis of DNA methylation and gene expression data for the diagnosis and underlying mechanism of Parkinson's disease.
Li D; Liang J; Guo W; Zhang Y; Wu X; Zhang W
Front Aging Neurosci; 2022; 14():971528. PubMed ID: 36062142
[TBL] [Abstract][Full Text] [Related]
34. Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.
Tang H; Kan L; Ou T; Chen D; Dou X; Wu W; Ji X; Wang M; Zong Z; Mo H; Zhang X; Xiong D
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441304
[TBL] [Abstract][Full Text] [Related]
35. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Zhu Q; Tian G; Gao J
Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
[TBL] [Abstract][Full Text] [Related]
36. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
37. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
38. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J
Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228
[No Abstract] [Full Text] [Related]
39. A methylation-based mRNA signature predicts survival in patients with gastric cancer.
Li Y; Sun R; Zhang Y; Yuan Y; Miao Y
Cancer Cell Int; 2020; 20():284. PubMed ID: 32647495
[TBL] [Abstract][Full Text] [Related]
40. A Linear Regression and Deep Learning Approach for Detecting Reliable Genetic Alterations in Cancer Using DNA Methylation and Gene Expression Data.
Mallik S; Seth S; Bhadra T; Zhao Z
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
